Rhythm Pharmaceuticals, Inc.
Clinical trials sponsored by Rhythm Pharmaceuticals, Inc., explained in plain language.
-
Hope for rare obesity: daily shot targets Brain-Related weight gain
Disease control Recruiting nowThis study tests a daily injection called setmelanotide to help people aged 4 and older who have severe weight gain due to a brain condition (hypothalamic obesity). Participants receive either the drug or a placebo for 26 weeks. The goal is to see if the drug reduces body mass in…
Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
New weekly shot targets genetic obesity in early trial
Disease control Recruiting nowThis study tests a new weekly injection called RM-718 in 150 people with obesity, including those with a genetic condition affecting the MC4R pathway (like Prader-Willi syndrome). The main goal is to check safety and how the drug moves through the body. It is an early-phase trial…
Phase: PHASE1, PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC